Österreichischer e-Health-Terminologie-Browser
0.6.1+20220411 - ci-build
Österreichischer e-Health-Terminologie-Browser
0.6.1+20220411 - ci-build
"Zuppl" terminologies are no longer supported and are considered to be legacy.
"Zuppl" terminologies represented FHIR Code System Supplements containing further attributes which were not present in the original CodeSystem resources. This intermediate step was necessary because this supplementary information on concepts could not be included in FHIR ValueSet resources. In the meantime information that was contained within the "Zuppl" terminolgies is now represented as designations within the ValueSet resources.
Summary
| Defining URL: | https://termgit.elga.gv.at/CodeSystem-zuppl-eimpf-impfstoffe-4-dgc-vaccinemarketingauthori |
| Version: | 202201.1 |
| Name: | zuppl-eimpf-impfstoffe-4-dgc-vaccinemarketingauthori |
| Status: | Active as of 2022-01-25 |
| Definition: | Description: To be used in certificate 2 |
| Content: | Supplement: This code system resource is a supplement to https://termgit.elga.gv.at/CodeSystem-eimpf-impfstoffe |
This Code system is referenced in the content logical definition of the following value sets:
Properties
| Code | Type | Description |
| concept_beschreibung | string | |
| relationships | string | |
| hinweise | string |
| Code | Display | concept_beschreibung | relationships | hinweise |
| 4989539 | COMIRNATY COV19 KONZ30 195x6 | Biontech Manufacturing GmbH | 2.16.840.1.113883.3.6905.4:ORG-100030215 | |
| 4990459 | VAXZEVRIA COV19 10x10 | AstraZeneca AB | 2.16.840.1.113883.3.6905.4:ORG-100001699 | |
| 4991720 | JANSSEN COV19 10x5 | Janssen-Cilag International | 2.16.840.1.113883.3.6905.4:ORG-100001417 | |
| 5424472 | PFIZER-BION COV19 KONZ30 1x6 | Biontech Manufacturing GmbH | 2.16.840.1.113883.3.6905.4:ORG-100030215 | |
| 5426867 | MODERNA/SPIKEVAX COV19 1x10 | Moderna Biotech Spain S.L. | 2.16.840.1.113883.3.6905.4:ORG-100031184 | |
| 5426873 | MODERNA/SPIKEVAX COV19 10x10 | Moderna Biotech Spain S.L. | 2.16.840.1.113883.3.6905.4:ORG-100031184 | |
| 5502522 | JANSSEN COV19 20x5 | Janssen-Cilag International | 2.16.840.1.113883.3.6905.4:ORG-100001417 | |
| 5506342 | COMIRNATY COV19 195x6 | Biontech Manufacturing GmbH | 2.16.840.1.113883.3.6905.4:ORG-100030215 | |
| 5506359 | COMIRNATY COV19 10x6 | Biontech Manufacturing GmbH | 2.16.840.1.113883.3.6905.4:ORG-100030215 | |
| 5506448 | COMIRNATY COV19 KONZ10 10x10 | Biontech Manufacturing GmbH | 2.16.840.1.113883.3.6905.4:ORG-100030215 | |
| 5611903 | NUVAXOVID COV19 1x10 | Novavax CZ, a.s. | 2.16.840.1.113883.3.6905.4:ORG-100032020 | |
| AUSL_000001 | COVID-19-Impfstoff CVnCoV (CureVac) | Curevac AG | 2.16.840.1.113883.3.6905.4:ORG-100006270 | |
| AUSL_000002 | COVID-19-Impfstoff NVX-CoV2373 (Novavax) | Novavax CZ, a.s. | 2.16.840.1.113883.3.6905.4:ORG-100032020 | DEPRECATED |
| AUSL_000003 | COVID-19-Impfstoff Sputnik-V (Gamaleya) | Gamaleya Research Institute | 2.16.840.1.113883.3.6905.4:Gamaleya-Research-Institute | |
| AUSL_000004 | COVID-19-Impfstoff Convidecia (CanSino Biologics) | CanSino Biologics | 2.16.840.1.113883.3.6905.4:ORG-100013793 | |
| AUSL_000005 | COVID-19-Impfstoff EpiVacCorona (Vektor-Institut) | Vector Institute | 2.16.840.1.113883.3.6905.4:Vector-Institute | |
| AUSL_000006 | COVID-19-Impfstoff BBIBP-CorV (Sinopharm) | China Sinopharm International Corp. - Beijing location | 2.16.840.1.113883.3.6905.4:ORG-100020693 | |
| AUSL_000008 | COVID-19-Impfstoff CoronaVac (Sinovac Biotech) | Sinovac Biotech | 2.16.840.1.113883.3.6905.4:Sinovac-Biotech | |
| AUSL_000009 | COVID-19-Impfstoff Covaxin (Bharat Biotech) | Bharat Biotech | 2.16.840.1.113883.3.6905.4:Bharat-Biotech | |
| AUSL_000010 | COVID-19-Impfstoff Covishield (Serum Institute of India) | Serum Institute of India | 2.16.840.1.113883.3.6905.4:ORG-100001981 | |
| AUSL_000011 | COVID-19-Impfstoff Covid-19 (recombinant) (Fiocruz) | Fiocruz | 2.16.840.1.113883.3.6905.4:Fiocruz | |
| AUSL_000012 | COVID-19-Impfstoff R-COVI (R-Pharm CJSC) | R-Pharm CJSC | 2.16.840.1.113883.3.6905.4:ORG-100007893 | |
| AUSL_000013 | COVID-19-Impfstoff CoviVac (Chumakov-Federal-Scientific-Center) | Chumakov-Federal-Scientific-Center | 2.16.840.1.113883.3.6905.4:Chumakov-Federal-Scientific-Center | |
| AUSL_000014 | COVID-19-Impfstoff Sputnik-Light (Gamaleya) | Gamaleya-Research-Institute | 2.16.840.1.113883.3.6905.4:Gamaleya-Research-Institute | |
| AUSL_000015 | COVID-19-Impfstoff Hayat-Vax (Gulf Pharmaceutical Industries) | Gulf Pharmaceutical Industries | 2.16.840.1.113883.3.6905.4:ORG-100023050 | |
| AUSL_000016 | COVID-19-Impfstoff Abdala (Center for Genetic Engineering and Biotechnology) | Center for Genetic Engineering and Biotechnology (CIGB) | 2.16.840.1.113883.3.6905.4:CIGB | |
| AUSL_000017 | COVID-19-Impfstoff WIBP-CorV (Sinopharm - Wuhan Institute of Biological Products) | Sinopharm - Wuhan Institute of Biological Products | 2.16.840.1.113883.3.6905.4:Sinopharm-WIBP | |
| AUSL_000018 | COVID-19-Impfstoff MVC COVID-19 vaccine (Medigen Vaccine Biologics Corporation) | Medigen Vaccine Biologics Corporation | 2.16.840.1.113883.3.6905.4:ORG-100033914 | |
| AUSL_000019 | COVID-19-Impfstoff Covovax (Serum Institute Of India Private Limited) | Serum Institute Of India Private Limited | 2.16.840.1.113883.3.6905.4:ORG-100001981 | |
| AUSL_000020 | COVID-19-Impfstoff Vidprevtyn (Sanofi Pasteur) | Sanofi Pasteur | 2.16.840.1.113883.3.6905.4:ORG-100000788 | |
| AUSL_000021 | COVID-19-Impfstoff VLA2001 (Valneva France) | Valneva France | 2.16.840.1.113883.3.6905.4:ORG-100036422 | |
| AUSL_000022 | COVID-19-Impfstoff EpiVacCorona-N (Vector Institute) | Vector Institute | 2.16.840.1.113883.3.6905.4:Vector-Institute | |
| AUSL_000023 | COVID-19-Impfstoff Sputnik-M (Gamaleya Research Institute) | Gamaleya Research Institute | 2.16.840.1.113883.3.6905.4:Gamaleya-Research-Institute |